Table 1.
Clinicopathological features of 157 patients with stage III colorectal cancer
| All, n = 157 (%) | |
|---|---|
| Age, years | 63.0 (56.0–70.0) |
| Gender | |
| Female | 71 (45.2) |
| Male | 86 (54.8) |
| Location | |
| Colon | 83 (52.9) |
| Rectum | 74 (47.1) |
| Preoperative CEA level | |
| ≤ 5 ng/ml | 89 (56.7) |
| > 5 ng/ml | 68 (43.3) |
| Histological type | |
| Well- or moderately differentiated | 150 (95.5) |
| Poorly differentiated | 7 (4.5) |
| Tumour invasion | |
| T1 | 2 (1.3) |
| T2 | 25 (15.9) |
| T3 | 108 (68.8) |
| T4 | 22 (14.0) |
| Lymph node status | |
| N1a | 111 (70.7) |
| N1b | 6 (3.8) |
| N1c | 4 (2.6) |
| N2a | 24 (15.3) |
| N2b | 12 (7.6) |
| Stage | |
| IIIA | 22 (14.0) |
| IIIB | 120 (76.4) |
| IIIC | 15 (9.6) |
| Adjuvant chemotherapy | |
| No | 32 (20.4) |
| Yes | 125 (79.6) |
| Follow-up, months | 66.0 (51.5–84.0) |